Estatinas en pacientes con síndrome coronario agudo. Más allá de las lipoproteínas de baja densidad

2012, The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, Lancet., 380, 581, 10.1016/S0140-6736(12)60367-5 Pfohl, 1999, Upregulation of cholesterol synthesis after acute myocardial infarction–is cholesterol a positive acute phase reactant?, Atherosclerosis., 142, 389, 10.1016/S0021-9150(98)00242-1 Weissberg, 1996, Is vascular smooth muscle cell proliferation beneficial?, Lancet., 347, 305, 10.1016/S0140-6736(96)90472-9 Aikawa, 2001, An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro, Circulation., 103, 276, 10.1161/01.CIR.103.2.276 Tsuda, 1996, Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia, Atherosclerosis., 122, 225, 10.1016/0021-9150(95)05757-9 Vaughan, 1996, Statins do more than just lower cholesterol, Lancet., 348, 1079, 10.1016/S0140-6736(96)05190-2 Lacoste, 1995, Hyperlipidemia and coronary disease: correction of the increased thrombogenic potential with cholesterol reduction, Circulation., 92, 3172, 10.1161/01.CIR.92.11.3172 Puccetti, 2002, Time-dependent effect of statins on platelet function in hypercholesterolaemia, Eur J Clin Invest., 32, 901, 10.1046/j.1365-2362.2002.01086.x Mihos, 2014, Cardiovascular effects of statins, beyond lipid-lowering properties, Pharmacol Res., 10.1016/j.phrs.2014.02.009 Laufs, 1998, Upregulation of endotelial nitric oxide synthase by HMG CoA reductasa inhibitors, Circulation., 47, 1129, 10.1161/01.CIR.97.12.1129 Dupuis, 1999, Cholesterol reduction rapidly improves endotelial function after acute coronary síndromes. The RECIFE (reduction of colesterol in ischemia and function of the endotelium) trial, Circulation., 99, 3227, 10.1161/01.CIR.99.25.3227 Ridker, 1999, Long term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators, Circulation., 100, 230, 10.1161/01.CIR.100.3.230 Link, 2006, Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome, Eur Heart J., 27, 2945, 10.1093/eurheartj/ehl277 Liem, 2002, Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial, Eur Heart J., 23, 1931, 10.1053/euhj.2002.3291 Thompson, 2004, Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial, Am Heart J., 148, e2, 10.1016/j.ahj.2003.10.052 Schwart, 2001, Effects of atorvastatin on early recurrent ischemic events in acute coronary síndromes: the MIRACL study: a randomized trial, JAMA, 285, 1711, 10.1001/jama.285.13.1711 De Lemos, 2004, Early intensive vs delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial, JAMA, 292, 1307, 10.1001/jama.292.11.1307 Cannon, 2004, Intensive vs moderate lipid lowering with statins after acute coronary síndromes, N Engl J Med., 350, 1495, 10.1056/NEJMoa040583 Pedersen, 2005, High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial, JAMA., 294, 2437, 10.1001/jama.294.19.2437 Blankenship, 2006, Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy), Am J Cardiol., 97, 1591, 10.1016/j.amjcard.2005.12.050 Briguori, 2009, Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction, J Am Coll Cardiol., 54, 2157, 10.1016/j.jacc.2009.07.005 Patti, 2007, Atorvastatin pretreatment improves outcomes in patients with acute coronary síndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial, J Am Coll Cardiol., 49, 1272, 10.1016/j.jacc.2007.02.025 Wang, 2013, Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes, J Cardiovasc Pharmacol Ther., 18, 327, 10.1177/1074248412474346 Kim, 2010, Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial, JACC Cardiovasc Interv, 3, 332, 10.1016/j.jcin.2009.11.021 Kim, 2014, Effect of high dose rosuvastatin loading before primary percutaneous coronary intervention on infarct size in patients with ST-segment elevation myocardial infarction, Korean Circ J., 44, 76, 10.4070/kcj.2014.44.2.76 Navarese, 2014, Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention, Am J Cardiol., 113, 1753, 10.1016/j.amjcard.2014.02.034 Reiner, 2011, ESC/EAS Guidelines for the management of dyslipidaemias, Eur Heart J., 32, 1769, 10.1093/eurheartj/ehr158 Di Sciascio, 2009, Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary interventions: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) randomized trial, J Am Coll Cardiol., 54, 558, 10.1016/j.jacc.2009.05.028 Cannon, 2008, Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes, Am Heart J., 156, 826, 10.1016/j.ahj.2008.07.023 Statins Evaluation in Coronary Procedures and Revascularization Trial. Disponible en: http://clinicaltrials.gov/ct2/show/NCT01448642?term=secure-pci&rank=1. The StaRT-CABG Trial. Disponible en: http://www.start-cabg.de/. Stone, 2014, 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults, J Am Coll Cardiol., 63, 2889, 10.1016/j.jacc.2013.11.002